OncoSec Medical Incorporated ONCS NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

OncoSec Medical Incorporated (ONCS) — Analyst outlook / Analyst consensus target is. Based on 3 analyst ratings, the consensus is bullish — 1 Buy, 2 Hold.

ONCS Analyst Ratings

Hold

Ratings

1 Buy

2 Hold

Based on 3 analysts giving stock ratings to OncoSec Medical Incorporated in the past 3 months

Rating breakdown

Buy

1 33%

Hold

2 67%

33%

Buy

1 analysts

67%

Hold

2 analysts

Sell

0 analysts

People Also View

ATNF

180 Life Sciences Corp.

$7.04

-7.49%

IMMX

Immix Biopharma, Inc.

Unicycive Therapeutics, Inc.

$6.94

+4.83%

ALLR

Allarity Therapeutics, Inc.

$1.19

-0.76%

PHIO

Phio Pharmaceuticals Corp.

First Wave BioPharma, Inc.

$2.96

+4.59%

OncoSec Medical Incorporated ONCS NASDAQ

ONCS Analyst Ratings

People Also View

Get Undervalued Stock Alerts